Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 123 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Merkel cell carcinoma of the eyelid management and prognosisHerbert, H.; Sun, M.; Selva, D.; Fernando, B.; Saleh, G.; Beaconsfield, M.; Collin, R.; Uddin, J.; Meligonis, G.; Leatherbarrow, B.; Ataullah, S.; Irion, L.; McLean, C.; Huilgol, S.; Davis, G.; Sullivan, T.
2021Update of a model to predict outcomes after endovascular aneurysm repairCowled, P.; Boult, M.; Barnes, M.; Fitridge, R.A.
2004Surgical margins for lentigo maligna and lentigo maligna melanoma - The technique of mapped serial excisionHuilgol, S.; Selva-Nayagam, D.; Chen, C.; Hill, D.; James, C.; Gramp, A.; Malhotra, R.
2018Long-term outcome of catheter ablation for treatment of bundle branch re-entrant tachycardiaPathak, R.; Fahed, J.; Santangeli, P.; Hyman, M.; Liang, J.; Kubala, M.; Hayashi, T.; Muser, D.; Pathak, M.; Kochar, A.; Castro, S.; Garcia, F.; Frankel, D.; Supple, G.; Schaller, R.; Lin, D.; Riley, M.; Deo, R.; Epstein, A.; Zado, E.; et al.
2004Modified Hughes flap - division at 7 daysLeibovitch, I.; Selva-Nayagam, D.
2014Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trialChow, E.; Meyer, R.; Chen, B.; van der Linden, Y.; Roos, D.; Hartsell, W.; Hoskin, P.; Wu, J.; Nabid, A.; Tissing-Tan, C.; Oei, B.; Babington, S.; Demas, W.; Wilson, C.; Wong, R.; Brundage, M.
2009Surgical outcomes of endoscopic management of adenocarcinoma of the sinonasal cavityJardeleza, C.; Seiberling, K.; Floreani, S.; Wormald, P.
2009Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancerSmit, E.; Burgers, S.; Biesma, B.; Smit, H.; Eppinga, P.; Dingemans, A.; Joerger, M.; Schellens, J.; Vincent, A.; van Zandwijk, N.; Groen, H.
2014Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)Falchook, G.; Long, G.; Kurzrock, R.; Kim, K.; Arkenau, H.; Brown, M.; Hamid, O.; Infante, J.; Millward, M.; Pavlick, A.; Chin, M.; O'Day, S.; Blackman, S.; Curtis, C.; Lebowitz, P.; Ma, B.; Ouellet, D.; Kefford, R.
2021The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort studyHodgson, C.L.; Higgins, A.M.; Bailey, M.J.; Mather, A.M.; Beach, L.; Bellomo, R.; Bissett, B.; Boden, I.J.; Bradley, S.; Burrell, A.; Cooper, D.J.; Fulcher, B.J.; Haines, K.J.; Hopkins, J.; Jones, A.Y.M.; Lane, S.; Lawrence, D.; van der Lee, L.; Liacos, J.; Linke, N.J.; et al.